INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
BIT:1ISRG • US46120E6023
410.85 EUR
-57.35 (-12.25%)
Last: Feb 5, 2026, 07:00 PM
Overall 1ISRG gets a fundamental rating of 7 out of 10. We evaluated 1ISRG against 65 industry peers in the Health Care Equipment & Supplies industry. 1ISRG scores excellent points on both the profitability and health parts. This is a solid base for a good stock. 1ISRG shows excellent growth, but is valued quite expensive already. With these ratings, 1ISRG could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
- In the past year 1ISRG was profitable.
- In the past year 1ISRG had a positive cash flow from operations.
- In the past 5 years 1ISRG has always been profitable.
- Each year in the past 5 years 1ISRG had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 13.96%, 1ISRG belongs to the best of the industry, outperforming 92.19% of the companies in the same industry.
- 1ISRG has a Return On Equity of 16.02%. This is amongst the best in the industry. 1ISRG outperforms 84.38% of its industry peers.
- The Return On Invested Capital of 1ISRG (13.95%) is better than 90.63% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for 1ISRG is above the industry average of 9.73%.
- The last Return On Invested Capital (13.95%) for 1ISRG is above the 3 year average (12.43%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.96% | ||
| ROE | 16.02% | ||
| ROIC | 13.95% |
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
1.3 Margins
- The Profit Margin of 1ISRG (28.38%) is better than 96.88% of its industry peers.
- 1ISRG's Profit Margin has improved in the last couple of years.
- 1ISRG has a better Operating Margin (29.35%) than 98.44% of its industry peers.
- In the last couple of years the Operating Margin of 1ISRG has grown nicely.
- 1ISRG has a better Gross Margin (66.00%) than 75.00% of its industry peers.
- 1ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.35% | ||
| PM (TTM) | 28.38% | ||
| GM | 66% |
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ISRG is creating some value.
- 1ISRG has less shares outstanding than it did 1 year ago.
- 1ISRG has more shares outstanding than it did 5 years ago.
- 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- 1ISRG has an Altman-Z score of 41.32. This indicates that 1ISRG is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of 1ISRG (41.32) is better than 98.44% of its industry peers.
- There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 41.32 |
ROIC/WACC1.44
WACC9.7%
2.3 Liquidity
- 1ISRG has a Current Ratio of 4.87. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
- 1ISRG's Current ratio of 4.87 is amongst the best of the industry. 1ISRG outperforms 96.88% of its industry peers.
- 1ISRG has a Quick Ratio of 3.96. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
- 1ISRG's Quick ratio of 3.96 is amongst the best of the industry. 1ISRG outperforms 95.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.87 | ||
| Quick Ratio | 3.96 |
3. Growth
3.1 Past
- 1ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.83%, which is quite impressive.
- 1ISRG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.42% yearly.
- 1ISRG shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.51%.
- The Revenue has been growing by 18.22% on average over the past years. This is quite good.
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%
3.2 Future
- 1ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.00% yearly.
- Based on estimates for the next years, 1ISRG will show a quite strong growth in Revenue. The Revenue will grow by 12.91% on average per year.
EPS Next Y14.46%
EPS Next 2Y14.31%
EPS Next 3Y14.59%
EPS Next 5Y14%
Revenue Next Year15.92%
Revenue Next 2Y14.87%
Revenue Next 3Y14.63%
Revenue Next 5Y12.91%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- 1ISRG is valuated quite expensively with a Price/Earnings ratio of 54.56.
- 1ISRG's Price/Earnings ratio is in line with the industry average.
- The average S&P500 Price/Earnings ratio is at 26.99. 1ISRG is valued rather expensively when compared to this.
- Based on the Price/Forward Earnings ratio of 47.68, the valuation of 1ISRG can be described as expensive.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 68.75% of the companies listed in the same industry.
- 1ISRG's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.02.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 54.56 | ||
| Fwd PE | 47.68 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than 65.63% of the companies in the same industry.
- The rest of the industry has a similar Price/Free Cash Flow ratio as 1ISRG.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 69.49 | ||
| EV/EBITDA | 45.27 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
- The excellent profitability rating of 1ISRG may justify a higher PE ratio.
- 1ISRG's earnings are expected to grow with 14.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.77
PEG (5Y)2.55
EPS Next 2Y14.31%
EPS Next 3Y14.59%
5. Dividend
5.1 Amount
- 1ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIT:1ISRG (2/5/2026, 7:00:00 PM)
410.85
-57.35 (-12.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/amc
Earnings (Next)04-20 2026-04-20/amc
Inst Owners88.29%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap145.91B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts78.1
Price Target533.94 (29.96%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)4.89%
PT rev (3m)2.43%
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)0.31%
EPS NY rev (1m)3%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)0.53%
Revenue NQ rev (3m)0.53%
Revenue NY rev (1m)1.01%
Revenue NY rev (3m)1.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 54.56 | ||
| Fwd PE | 47.68 | ||
| P/S | 17.2 | ||
| P/FCF | 69.49 | ||
| P/OCF | 57.11 | ||
| P/B | 9.71 | ||
| P/tB | 9.93 | ||
| EV/EBITDA | 45.27 |
EPS(TTM)7.53
EY1.83%
EPS(NY)8.62
Fwd EY2.1%
FCF(TTM)5.91
FCFY1.44%
OCF(TTM)7.19
OCFY1.75%
SpS23.89
BVpS42.31
TBVpS41.39
PEG (NY)3.77
PEG (5Y)2.55
Graham Number84.67
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.96% | ||
| ROE | 16.02% | ||
| ROCE | 16.01% | ||
| ROIC | 13.95% | ||
| ROICexc | 20.73% | ||
| ROICexgc | 21.4% | ||
| OM | 29.35% | ||
| PM (TTM) | 28.38% | ||
| GM | 66% | ||
| FCFM | 24.75% |
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 79.72% | ||
| Cap/Sales | 5.36% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.46% | ||
| Profit Quality | 87.21% | ||
| Current Ratio | 4.87 | ||
| Quick Ratio | 3.96 | ||
| Altman-Z | 41.32 |
F-Score8
WACC9.7%
ROIC/WACC1.44
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
EPS Next Y14.46%
EPS Next 2Y14.31%
EPS Next 3Y14.59%
EPS Next 5Y14%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%
Revenue Next Year15.92%
Revenue Next 2Y14.87%
Revenue Next 3Y14.63%
Revenue Next 5Y12.91%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year34.54%
EBIT Next 3Y22.15%
EBIT Next 5Y17.41%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%
INTUITIVE SURGICAL INC / 1ISRG.MI FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1ISRG.MI.
What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?
ChartMill assigns a valuation rating of 1 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.
Can you provide the profitability details for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for 1ISRG stock?
The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 54.56 and the Price/Book (PB) ratio is 9.71.
Can you provide the financial health for 1ISRG stock?
The financial health rating of INTUITIVE SURGICAL INC (1ISRG.MI) is 7 / 10.